| Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells D Duluc, Y Delneste, F Tan, MP Moles, L Grimaud, J Lenoir, L Preisser, ... Blood, The Journal of the American Society of Hematology 110 (13), 4319-4330, 2007 | 602 | 2007 |
| Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells G Caron, D Duluc, I Frémaux, P Jeannin, C David, H Gascan, Y Delneste The Journal of Immunology 175 (3), 1551-1557, 2005 | 532 | 2005 |
| Interferon‐γ reverses the immunosuppressive and protumoral properties and prevents the generation of human tumor‐associated macrophages D Duluc, M Corvaisier, S Blanchard, L Catala, P Descamps, E Gamelin, ... International journal of cancer 125 (2), 367-373, 2009 | 371 | 2009 |
| T follicular helper cells in autoimmune disorders N Gensous, M Charrier, D Duluc, C Contin-Bordes, ME Truchetet, ... Frontiers in immunology 9, 1637, 2018 | 194 | 2018 |
| Targeting self- and foreign antigens to dendritic cells via DC-ASGPR generates IL-10–producing suppressive CD4+ T cells D Li, G Romain, AL Flamar, D Duluc, M Dullaers, XH Li, S Zurawski, ... Journal of Experimental Medicine 209 (1), 109-121, 2012 | 193 | 2012 |
| The IL-27 p28 subunit binds cytokine-like factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling S Crabe, A Guay-Giroux, AJ Tormo, D Duluc, R Lissilaa, F Guilhot, ... The Journal of Immunology 183 (12), 7692-7702, 2009 | 147 | 2009 |
| Histamine and prostaglandin E2 up‐regulate the production of Th2‐attracting chemokines (CCL17 and CCL22) and down‐regulate IFN‐γ‐induced CXCL10 … A McIlroy, G Caron, S Blanchard, I Frémaux, D Duluc, Y Delneste, ... Immunology 117 (4), 507-516, 2006 | 121 | 2006 |
| Chemoradiotherapy-induced upregulation of PD-1 antagonizes immunity to HPV-related oropharyngeal cancer F Parikh, D Duluc, N Imai, A Clark, K Misiukiewicz, M Bonomi, V Gupta, ... Cancer research 74 (24), 7205-7216, 2014 | 103 | 2014 |
| Beyond the tumour microenvironment L Laplane, D Duluc, A Bikfalvi, N Larmonier, T Pradeu International journal of cancer 145 (10), 2611-2618, 2019 | 95 | 2019 |
| Functional diversity of human vaginal APC subsets in directing T-cell responses D Duluc, J Gannevat, E Anguiano, S Zurawski, M Carley, M Boreham, ... Mucosal immunology 6 (3), 626-638, 2013 | 89 | 2013 |
| Concomitant activation and antigen uptake via human dectin-1 results in potent antigen-specific CD8+ T cell responses L Ni, I Gayet, S Zurawski, D Duluc, AL Flamar, XH Li, A O’Bar, S Clayton, ... The Journal of Immunology 185 (6), 3504-3513, 2010 | 88 | 2010 |
| Functional specialty of CD40 and dendritic cell surface lectins for exogenous antigen presentation to CD8+ and CD4+ T cells W Yin, L Gorvel, S Zurawski, D Li, L Ni, D Duluc, K Upchurch, JR Kim, ... EBioMedicine 5, 46-58, 2016 | 78 | 2016 |
| The multiple layers of the tumor environment L Laplane, D Duluc, N Larmonier, T Pradeu, A Bikfalvi Trends in cancer 4 (12), 802-809, 2018 | 77 | 2018 |
| IL-6 and leukemia-inhibitory factor are involved in the generation of tumor-associated macrophage: regulation by IFN-γ P Jeannin, D Duluc, Y Delneste Immunotherapy 3 (sup4), 23-26, 2011 | 74 | 2011 |
| IL-26 is overexpressed in chronically HCV-infected patients and enhances TRAIL-mediated cytotoxicity and interferon production by human NK cells C Miot, E Beaumont, D Duluc, H Le Guillou-Guillemette, L Preisser, ... Gut 64 (9), 1466-1475, 2015 | 63 | 2015 |
| C-type lectin-like receptor LOX-1 promotes dendritic cell-mediated class-switched B cell responses HM Joo, D Li, M Dullaers, TW Kim, D Duluc, K Upchurch, Y Xue, ... Immunity 41 (4), 592-604, 2014 | 62 | 2014 |
| PolyI:C plus IL‐2 or IL‐12 induce IFN‐γ production by human NK cells via autocrine IFN‐β D Duluc, F Tan, M Scotet, S Blanchard, I Frémaux, E Garo, B Horvat, P Eid, ... European journal of immunology 39 (10), 2877-2884, 2009 | 44 | 2009 |
| Increase of follicular helper T cells skewed toward a Th1 profile in CVID patients with non-infectious clinical complications D Turpin, A Furudoi, M Parrens, P Blanco, JF Viallard, D Duluc Clinical Immunology 197, 130-138, 2018 | 37 | 2018 |
| The Antigen-Presenting Potential of Vγ9Vδ2 T Cells During Plasmodium falciparum Blood-Stage Infection J Howard, S Loizon, CJ Tyler, D Duluc, B Moser, M Mechain, ... The Journal of infectious diseases 215 (10), 1569-1579, 2017 | 35 | 2017 |
| Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity W Yin, D Duluc, HM Joo, Y Xue, C Gu, Z Wang, L Wang, R Ouedraogo, ... Cancer immunology research 4 (10), 823-834, 2016 | 31 | 2016 |
